DiscoverBioTech Nation ... with Dr. Moira GunnTreating the Untreatable in Rheumatoid Arthritis! Rob Armstrong, CEO, Artax Biopharma
Treating the Untreatable in Rheumatoid Arthritis! Rob Armstrong, CEO, Artax Biopharma

Treating the Untreatable in Rheumatoid Arthritis! Rob Armstrong, CEO, Artax Biopharma

Update: 2025-10-29
Share

Description

40% of all rheumatoid arthritis patients do not respond to any of the current drugs. Rob Armstrong, CEO of Artax Biopharma, aims to bring new hope for those patients who've been left without effective treatment options.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Treating the Untreatable in Rheumatoid Arthritis! Rob Armstrong, CEO, Artax Biopharma

Treating the Untreatable in Rheumatoid Arthritis! Rob Armstrong, CEO, Artax Biopharma

Moira Gunn